Assessment of gene signatures following the inhibition of IL-23: a study to evaluate the mechanistic effects behind the clinical efficacy of guselkumab in patients with psoriatic arthritis

Our findings may give further insights into manipulated mechanistic pathways by IL-23 inhibition in patients with PSO and PSA.

Authors

Maria Esposito (ORCID: https://orcid.org/0000-0002-4773-6993)
Cristina Pellegrini (ORCID: https://orcid.org/0000-0003-2168-8097)
Paola Cipriani (ORCID: https://orcid.org/0000-0002-2000-4661)
Piero Ruscitti (ORCID: https://orcid.org/0000-0003-3487-8551)
Maria Concetta Fargnoli (ORCID: https://orcid.org/0000-0002-7249-2556)
Mirco Mastrangelo (ORCID: https://orcid.org/0000-0003-2232-7090)
Manfredo Bruni (ORCID: https://orcid.org/0000-0001-9357-9653)
Andrea De Berardinis (ORCID: https://orcid.org/0009-0008-6388-1438)
Antonio Barile (ORCID: https://orcid.org/0000-0003-0253-3583)
Eleonora Lucantonio